• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用微小、恒定的诺氏疟原虫66kD裂殖子抗原对恒河猴进行疫苗接种试验。

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen.

作者信息

Deans J A, Knight A M, Jean W C, Waters A P, Cohen S, Mitchell G H

机构信息

Department of Immunology, UMDS, Guy's Hospital Medical School, London.

出版信息

Parasite Immunol. 1988 Sep;10(5):535-52. doi: 10.1111/j.1365-3024.1988.tb00241.x.

DOI:10.1111/j.1365-3024.1988.tb00241.x
PMID:3194149
Abstract

A minor Plasmodium knowlesi 66 kD antigen, which plays an essential role in merozoite invasion, has been shown to be stable in distinct variants and strains of the parasite, and in the face of a specific immune response from the host. Parasites were unable to produce novel molecule(s) to replace it functionally, even in the presence of specific immune pressure. Rhesus monkeys immunized with the purified 66 kD antigen, with saponin as adjuvant, produced antibody which inhibited merozoite invasion of red cells in vitro. Four out of six immunized rhesus monkeys demonstrated clinically effective immunity when challenged at a time of known or presumed high inhibitory antibody titre. When immunization failed to protect, it was ascribed to insufficient levels of specific antibody attributable either to a suboptimal dose of antigen or the use of an inadequate adjuvant.

摘要

诺氏疟原虫一种分子量为66 kD的次要抗原,在裂殖子入侵过程中发挥着至关重要的作用,已被证明在该寄生虫的不同变体和菌株中以及面对宿主的特异性免疫反应时都很稳定。即使存在特异性免疫压力,寄生虫也无法产生新的分子来在功能上替代它。用纯化的66 kD抗原并以皂苷作为佐剂免疫恒河猴,产生了在体外抑制裂殖子入侵红细胞的抗体。六只免疫的恒河猴中有四只在已知或推测为高抑制性抗体滴度时受到攻击时表现出临床有效的免疫力。当免疫未能起到保护作用时,这归因于特异性抗体水平不足,这要么是由于抗原剂量次优,要么是由于使用了不充分的佐剂。

相似文献

1
Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen.用微小、恒定的诺氏疟原虫66kD裂殖子抗原对恒河猴进行疫苗接种试验。
Parasite Immunol. 1988 Sep;10(5):535-52. doi: 10.1111/j.1365-3024.1988.tb00241.x.
2
Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria.诺氏疟原虫疟疾140kD裂殖子表面抗原的疫苗接种诱导变异。
J Exp Med. 1987 Feb 1;165(2):359-67. doi: 10.1084/jem.165.2.359.
3
Protective antigens of bloodstage Plasmodium knowlesi parasites.诺氏疟原虫血液期寄生虫的保护性抗原
Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):159-69. doi: 10.1098/rstb.1984.0116.
4
Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.用诺氏疟原虫140千道尔顿裂殖子表面蛋白对猴子进行免疫:该蛋白交替形式的出现。
J Immunol. 1985 Jun;134(6):4146-52.
5
Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques.疟原虫感染的子孢子挑战后,恒河猴经 DNA 疫苗初免、痘病毒疫苗加强免疫策略,可诱导针对红内期抗原的高功能抗体滴度。
Malar J. 2011 Feb 8;10:29. doi: 10.1186/1475-2875-10-29.
6
Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.用脆弱疟原虫重组顶端膜抗原-1在松鼠猴中诱导的保护性免疫。
Am J Trop Med Hyg. 1994 Dec;51(6):711-9. doi: 10.4269/ajtmh.1994.51.711.
7
Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.用于诺氏疟原虫疟疾的多阶段多抗原异源初免-加强疫苗在恒河猴中提供部分保护。
Infect Immun. 2001 Sep;69(9):5565-72. doi: 10.1128/IAI.69.9.5565-5572.2001.
8
Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.恒河猴疟疾疫苗对间日疟原虫的无菌保护作用:不同异源初免-加强策略的比较。
PLoS One. 2009 Aug 10;4(8):e6559. doi: 10.1371/journal.pone.0006559.
9
Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes.诺氏疟原虫74000道尔顿抗原在裂殖体感染的恒河猴红细胞膜中的保护作用
J Exp Med. 1983 Jul 1;158(1):146-58. doi: 10.1084/jem.158.1.146.
10
Merozoite vaccination against Plasmodium knowlesi malaria.用疟原虫裂殖子接种预防诺氏疟原虫疟疾。
Immunology. 1975 Aug;29(2):397-407.

引用本文的文献

1
Natural selection on apical membrane antigen 1 (AMA1) of an emerging zoonotic malaria parasite Plasmodium inui.自然选择对新兴人畜共患疟原虫 Inui 属的顶膜抗原 1(AMA1)的影响。
Sci Rep. 2024 Oct 9;14(1):23637. doi: 10.1038/s41598-024-74785-8.
2
Current status of experimental models for the study of malaria.疟疾研究实验模型的现状
Parasitology. 2022 Feb 21;149(6):1-22. doi: 10.1017/S0031182021002134.
3
Genetic diversity of Plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development.
来自印度东北部的特里普拉邦的恶性疟原虫 AMA-1 抗原的遗传多样性与全球序列的比较:对疫苗开发的影响。
Malar J. 2022 Feb 22;21(1):62. doi: 10.1186/s12936-022-04081-1.
4
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses.疟疾疫苗候选物PfAMA1 DiCo的加速Ia/b期评估显示体液免疫反应范围扩大。
NPJ Vaccines. 2021 Apr 14;6(1):55. doi: 10.1038/s41541-021-00319-2.
5
The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes.疟疾疫苗的探索:改良免疫增强探针的时代
Vaccines (Basel). 2021 Feb 2;9(2):115. doi: 10.3390/vaccines9020115.
6
Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.疟原虫 falciparum AMA1 特异性人源单克隆抗体的分离和轻链改组及其生长抑制活性。
Malar J. 2021 Jan 11;20(1):37. doi: 10.1186/s12936-020-03548-3.
7
-mediated zoonotic malaria: A challenge for elimination.媒介传播的人畜共患疟疾:消除工作面临的一项挑战。
Trop Parasitol. 2020 Jan-Jun;10(1):3-6. doi: 10.4103/tp.TP_17_18. Epub 2020 May 20.
8
Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response.恶性疟原虫 AMA1:不同单倍型对免疫反应的影响。
PLoS Negl Trop Dis. 2020 Jul 8;14(7):e0008471. doi: 10.1371/journal.pntd.0008471. eCollection 2020 Jul.
9
In vitro invasion inhibition assay using antibodies against Plasmodium knowlesi Duffy binding protein alpha and apical membrane antigen protein 1 in human erythrocyte-adapted P. knowlesi A1-H.1 strain.在体外使用针对恶性疟原虫 Duffy 结合蛋白 alpha 和顶膜抗原蛋白 1 的抗体抑制疟原虫入侵人血红细胞适应株 P. knowlesi A1-H.1 的实验。
Malar J. 2018 Jul 27;17(1):272. doi: 10.1186/s12936-018-2420-4.
10
Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes.恶性疟原虫配体-受体相互作用:PvAMA-1 结构域 I 包含与 CD71+网织红细胞特异性相互作用的最小区域。
Sci Rep. 2017 Aug 30;7(1):9616. doi: 10.1038/s41598-017-10025-6.